公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2023 | PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib | Chan, Chien-Hui; Chiou, Li-Wen; Lee, Tsai-Yu; Liu, Yun-Ru; Hsieh, Tsung-Han; CHING-YAO YANG ; YUNG-MING JENG | British journal of cancer | 9 | 9 | |
2017 | Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan | MING-CHU CHANG ; CHIH-HORNG WU ; SHIH HUNG YANG ; PO-CHIN LIANG ; BANG-BIN CHEN ; I-SHIOW JAN ; YU-TING CHANG ; YUNG-MING JENG | American Journal of Cancer Research | 15 | | |
2023 | Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways | YU-TING CHANG ; Peng, Hsuan-Yu; Hu, Chun-Mei; Tien, Sui-Chih; Chen, Yi-Ing; YUNG-MING JENG ; Chang, Ming-Chu | Molecular oncology | 2 | 1 | |
2016 | Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion | Lee Y.-H.; Jhuang Y.-L.; Chen Y.-L.; YUNG-MING JENG ; RAY-HWANG YUAN | Oncotarget | 13 | 14 | |
2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |
2012 | Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation | HSIANG-PO HUANG ; MEI-HWEI CHANG ; Chen Y.-T.; HONG-YUAN HSU ; Chiang C.-L.; Cheng T.-S.; YAO-MING WU ; MU-ZON WU ; Hsu Y.-C.; Shen C.-C.; Lee C.-N.; YA-HUI CHUANG ; Hong C.-L.; YUNG-MING JENG ; Chen P.-H.; HUEY-LING CHEN ; MING-SHYUE LEE | Hepatology | 10 | 10 | |
2007 | Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma | CHIEN-HUNG CHEN ; Lee, Hsuan-Shu ; GUAN-TARN HUANG ; PEI-MING YANG ; Yu W.-A.; Cheng K.-C.; PO-HUANG LEE ; YUNG-MING JENG ; DING-SHINN CHEN ; JIN-CHUAN SHEU | Hepato-Gastroenterology | 5 | 5 | |
1996 | Phenytoin-induced pseudolymphoma: Reevaluation using modern molecular biology techniques | YUNG-MING JENG ; HWEI-FANG TIEN ; Su I.-J. | Epilepsia | 25 | 14 | |
2011 | Phosphorylation of NuSAP by Cdk1 regulates its interaction with microtubules in mitosis | HAN-YI E. CHOU ; Wang T.-H.; Lee S.-C.; Hsu P.-H.; Tsai M.-D.; Chang C.-N.; YUNG-MING JENG | Cell Cycle | 22 | 16 | |
2023 | PIM1-Induced Cytoplasmic Expression of RBMY Mediates Hepatocellular Carcinoma Metastasis | Chua, Huey-Huey; MEI-HWEI CHANG ; Chen, Ya-Hui; Tsuei, Daw-Jen; YUNG-MING JENG ; PO-HUANG LEE ; YEN-HSUAN NI | Cellular and molecular gastroenterology and hepatology | 2 | 1 | |
2019 | Plectin Mutations in Progressive Familial Intrahepatic Cholestasis | Wu S.-H.; Jacob Shujui Hsu ; HUEY-LING CHEN ; Chien M.-M.; JIA-FENG WU ; YEN-HSUAN NI ; Liou B.-Y.; MING-CHIH HO ; YUNG-MING JENG ; MEI-HWEI CHANG ; PEI-LUNG CHEN | Hepatology | 10 | 7 | |
2006 | Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: Report of five pediatric cases | Lai Y.-C.; YEN-HSUAN NI ; SHIANN-TANG JOU ; MING-CHIH HO ; JIA-FENG WU ; HUEY-LING CHEN ; REY-HENG HU ; YUNG-MING JENG ; MEI-HWEI CHANG ; PO-HUANG LEE | Pediatric Transplantation | 19 | 17 | |
2014 | Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma | DA-LIANG OU ; Chang C.-J.; YUNG-MING JENG ; Lin Y.-J.; ZHONG-ZHE LIN ; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; CHIUN HSU ; ANN-LII CHENG | Journal of Gastroenterology and Hepatology (Australia) | 9 | 13 | |
2001 | Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children | Yang Y.-J.; JYH-CHIN YANG ; YUNG-MING JENG ; MEI-HWEI CHANG ; YEN-HSUAN NI | Pediatric Infectious Disease Journal | 32 | 28 | |
2010 | Primary biliary cirrhosis associated with pernicious anemia | Chung C.-S.; Hsu Y.-C.; SHANG-YI HUANG ; YUNG-MING JENG ; CHIEN-HUNG CHEN | Canadian Family Physician | 6 | 5 | |
2002 | Primary yolk sac tumor of the urachus: Case report with immunohistochemical and flow cytometric studies | Huang H.-Y.; Ko S.-F.; Chuang J.-H.; YUNG-MING JENG ; Sung M.-T.; Chen W.-J. | Archives of Pathology and Laboratory Medicine | 26 | 17 | |
2010 | Prognostic implication of MET overexpression in myxofibrosarcomas: An integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis | JEN-CHIEH LEE ; Li C.-F.; Fang F.-M.; Wang J.-W.; YUNG-MING JENG ; Yu S.C.; Lin Y.-T.; Wu J.-M.; Tsai J.-W.; Li S.-H.; Huang H.-Y. | Modern Pathology | 29 | 25 | |
2020 | The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma | HSIU-HAO CHANG ; MENG-YAO LU ; YUNG-LI YANG ; SHU-WEI CHOU ; Lin D.-T.; Lin K.-H.; WEN-MING HSU ; YUNG-MING JENG ; SHIANN-TANG JOU | Journal of Clinical Pathology | 24 | 20 | |
2015 | Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration | Chou C.-T.; Li Y.-J.; Chang C.-C.; Yang C.-N.; Li P.-S.; YUNG-MING JENG ; Chen S.-T.; Kuo M.-L.; Lin I.-C.; BEEN-REN LIN | Annals of Surgical Oncology | 11 | 10 | |
2009 | Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma | YUNG-MING JENG ; Wang T.-H.; Lu S.-H.; RAY-HWANG YUAN ; Hsu H.-C. | British Journal of Surgery | 29 | 25 | |